| Ytd | -5.50% | |
| 1y | -28.64% |
| Open | 42.66 | Prev Close | 41.95 | Low | 42.51 | High | 44.58 | Mkt Cap | 1.10B |
| Vol | 262.60K | Avg Vol | 318.98K | EPS | 1.37 | P/E | 32.20 | Forward P/E | 7.98 |
| Beta | 0.73 | Short Ratio | 2.52 | Inst. Own | 100.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 42.08 | 200-d Avg | 47.29 | 1yr Est | 63.00 |
HG, DFIN and EFXT made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 30, 2026.
DA Davidson analyst Peter Heckmann maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and
GuidanceThe Company provides the following guidance for the second quarter of 2026. Second-Quarter G
DA Davidson analyst Peter Heckmann maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and
GuidanceThe Company provides the following guidance for the first quarter of 2026: First-Quarter Gui
Donnelley Financial Solns (NYSE:DFIN) reported quarterly earnings of $0.70 per share which beat the
Needham analyst Kyle Peterson reiterates Donnelley Financial Solns (NYSE:DFIN) with a Buy and mai
Needham analyst Kyle Peterson maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and lowe
Donnelley Financial Solns (NYSE:DFIN) sees Q4 sales of $150.000 million-$160.000 million vs $165.435
Donnelley Financial Solns (NYSE:DFIN) reported quarterly earnings of $0.86 per share which beat the
Needham analyst Kyle Peterson reiterates Donnelley Financial Solns (NYSE:DFIN) with a Buy and mai
Needham analyst Kyle Peterson maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and main
Donnelley Financial Solns (NYSE:DFIN) reported quarterly earnings of $1.24 per share which beat the
DA Davidson analyst Peter Heckmann maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and
DA Davidson analyst Peter Heckmann maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and
Needham analyst Kyle Peterson reiterates Donnelley Financial Solns (NYSE:DFIN) with a Buy and mai
DA Davidson analyst Peter Heckmann maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and
Needham analyst Kyle Peterson maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and lowe
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent ge
Donnelley Financial Solns (NYSE:DFIN) reported quarterly earnings of $0.40 per share which missed th
Needham analyst Kyle Peterson reiterates Donnelley Financial Solns (NYSE:DFIN) with a Buy and mai
B. Riley Securities analyst Raj Sharma maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy
Needham analyst Kyle Peterson reiterates Donnelley Financial Solns (NYSE:DFIN) with a Buy and mai
Donnelley Financial Solns (NYSE:DFIN) reported quarterly earnings of $0.48 per share which missed th
Needham analyst Kyle Peterson reiterates Donnelley Financial Solns (NYSE:DFIN) with a Buy and mai
DA Davidson analyst Peter Heckmann maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and
Needham analyst Kyle Peterson maintains Donnelley Financial Solns (NYSE:DFIN) with a Buy and rais
Donnelley Financial Solns (NYSE:DFIN) reported quarterly earnings of $1.66 per share which beat the
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results
U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Wednesday. Here
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report